manufacturingchemist

Lonza launches enhanced DNA-to-IND offering, enabling IND readiness in as Little as six months for more complex biologics

Lonza, the world’s leading contract development and manufacturing organisation (CDMO), announced today the expansion of its ...
manufacturingchemist

ScionxBio and Sanofi partner on long-acting mRNA therapies

The collaboration will combine Sanofi’s mRNA drug candidates with ScionxBio’s AI-driven TERA platform to develop ...
manufacturingchemist

Prescription for resilience: how climate volatility is redefining the business of pharma

As climate disruption reshapes global disease patterns and strains precision supply chains, the healthcare sector faces a ...
manufacturingchemist

Lonza upgrades organic growth model and mid-term financial ambitions at capital Markets Day; Q3 2026 in line with expectations

At its Capital Markets Day in Vacaville, California, Lonza reports progress of its One Lonza Strategy to deliver long-term, ...
manufacturingchemist

Amgen and AstraZeneca report positive Phase III results for Tezspire in EoE

Tezspire improved swallowing symptoms and reduced oesophageal inflammation in patients with eosinophilic oesophagitis, with ...